✦ LIBER ✦

Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus

✍ Scribed by Barile-Fabris, L

Book ID: 124101685
Publisher: BMJ Publishing Group
Year: 2005
Tongue: English
Weight: 104 KB
Volume: 64
Category: Article
ISSN: 0003-4967
DOI: 10.1136/ard.2004.025528

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Controlled trial of pulse methylpredniso

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

✍ Boumpas, D.T.; Austin, H.A.; Balow, J.E.; Vaughan, E.M.; Yarboro, C.H.; Klippel, 📂 Article 📅 1992 🏛 The Lancet 🌐 English ⚖ 653 KB

Emergence of manifestations of HIV infec

Emergence of manifestations of HIV infection in a case of systemic lupus erythematosus following treatment with IV cyclophosphamide

✍ Indrajit Hazarika; Bhabani Prasad Chakravarty; Sangit Dutta; Neelakshi Mahanta 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 165 KB

The effect of moderate-dose corticostero

The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: Findings of a prospective, randomized, double-blind, placebo-controlled trial

✍ Chung-E Tseng; Jill P. Buyon; Mimi Kim; H. Michael Belmont; Meggan Mackay; Betty 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

## Abstract ## Objective Serial measurements of anti–double‐stranded DNA (anti‐dsDNA) and complement are routine in the management of systemic lupus erythematosus (SLE), but their utility as biomarkers in preemptive treatment to prevent flares remains a subject of controversy. We hypothesized that